The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease

von Willebrand factor (VWF) is an adhesive protein involved in primary hemostasis and facilitates platelet adhesion to sites of vascular injury, thereby promoting thrombus formation. VWF exists in plasma as multimers of increasing size, with the largest (high molecular weight; HMW) expressing the gr...

Full description

Bibliographic Details
Main Authors: Benjamin Reardon, Leonardo Pasalic, Emmanuel J. Favaloro
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
Online Access:https://www.mdpi.com/2308-3425/8/9/115
_version_ 1829092247313842176
author Benjamin Reardon
Leonardo Pasalic
Emmanuel J. Favaloro
author_facet Benjamin Reardon
Leonardo Pasalic
Emmanuel J. Favaloro
author_sort Benjamin Reardon
collection DOAJ
description von Willebrand factor (VWF) is an adhesive protein involved in primary hemostasis and facilitates platelet adhesion to sites of vascular injury, thereby promoting thrombus formation. VWF exists in plasma as multimers of increasing size, with the largest (high molecular weight; HMW) expressing the greatest functional activity. A deficiency of VWF is associated with a bleeding disorder called von Willebrand disease (VWD), whereas an excess of VWF, in particular the HMW forms, is associated with thrombosis. ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif-13), also known as VWF-cleaving protease, functions to moderate the activity of VWF by cleaving multimers of VWF and limiting the expression of the largest multimers of VWF. A deficiency of ADAMTS13 is therefore associated with an excess of (HMW forms of) VWF, and thus thrombosis. Indeed, any disturbance of the VWF/ADAMTS13 ratio or ‘axis’ may be associated with pathophysiological processes, including prothrombotic tendency. However, both thrombosis or bleeding may be associated with such disturbances, depending on the presenting events. This review evaluates the relationship of VWF and ADAMTS13 with cardiac disease, including cardiac failure, and associated pathophysiology.
first_indexed 2024-03-10T07:33:35Z
format Article
id doaj.art-2c010d86da99483ca54175bc8516c01b
institution Directory Open Access Journal
issn 2308-3425
language English
last_indexed 2024-03-10T07:33:35Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Journal of Cardiovascular Development and Disease
spelling doaj.art-2c010d86da99483ca54175bc8516c01b2023-11-22T13:38:24ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252021-09-018911510.3390/jcdd8090115The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac DiseaseBenjamin Reardon0Leonardo Pasalic1Emmanuel J. Favaloro2Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, NSW 2145, AustraliaInstitute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, NSW 2145, AustraliaInstitute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, NSW 2145, Australiavon Willebrand factor (VWF) is an adhesive protein involved in primary hemostasis and facilitates platelet adhesion to sites of vascular injury, thereby promoting thrombus formation. VWF exists in plasma as multimers of increasing size, with the largest (high molecular weight; HMW) expressing the greatest functional activity. A deficiency of VWF is associated with a bleeding disorder called von Willebrand disease (VWD), whereas an excess of VWF, in particular the HMW forms, is associated with thrombosis. ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif-13), also known as VWF-cleaving protease, functions to moderate the activity of VWF by cleaving multimers of VWF and limiting the expression of the largest multimers of VWF. A deficiency of ADAMTS13 is therefore associated with an excess of (HMW forms of) VWF, and thus thrombosis. Indeed, any disturbance of the VWF/ADAMTS13 ratio or ‘axis’ may be associated with pathophysiological processes, including prothrombotic tendency. However, both thrombosis or bleeding may be associated with such disturbances, depending on the presenting events. This review evaluates the relationship of VWF and ADAMTS13 with cardiac disease, including cardiac failure, and associated pathophysiology.https://www.mdpi.com/2308-3425/8/9/115von Willebrand factorendotheliumcardiac failureADAMTS13
spellingShingle Benjamin Reardon
Leonardo Pasalic
Emmanuel J. Favaloro
The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
Journal of Cardiovascular Development and Disease
von Willebrand factor
endothelium
cardiac failure
ADAMTS13
title The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
title_full The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
title_fullStr The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
title_full_unstemmed The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
title_short The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
title_sort intriguing relationships of von willebrand factor adamts13 and cardiac disease
topic von Willebrand factor
endothelium
cardiac failure
ADAMTS13
url https://www.mdpi.com/2308-3425/8/9/115
work_keys_str_mv AT benjaminreardon theintriguingrelationshipsofvonwillebrandfactoradamts13andcardiacdisease
AT leonardopasalic theintriguingrelationshipsofvonwillebrandfactoradamts13andcardiacdisease
AT emmanueljfavaloro theintriguingrelationshipsofvonwillebrandfactoradamts13andcardiacdisease
AT benjaminreardon intriguingrelationshipsofvonwillebrandfactoradamts13andcardiacdisease
AT leonardopasalic intriguingrelationshipsofvonwillebrandfactoradamts13andcardiacdisease
AT emmanueljfavaloro intriguingrelationshipsofvonwillebrandfactoradamts13andcardiacdisease